Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Poland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20041
20051
20062
20071
20081
20114
20151
20162
20172
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Hoffmann-La Roche2
Jagiellonian University2
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)1
Bayer1
Eli Lilly and Company1
Esperas Pharma Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
GlaxoSmithKline1
Medical University of Silesia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms21
Neoplasms5
Colorectal Neoplasms4
Stomach Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Endocrine Gland Neoplasms2
Endometrial Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.